Valeant 'Puzzled' Over Document Withholding Accusations
This article was originally published in Scrip
Executive Summary
Valeant Pharmaceuticals International Inc. on March 10 said it was "surprised and puzzled" by the accusations from the Republican and Democratic heads of the House Oversight and Government Reform Committee that the firm was withholding documents.